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Revised diagnostic criteria set forth in the 2008 MSA consensus
statement

A diagnosis of definite MSA is based upon postmortem pathology showing alpha-synuclein-positive
glial cytoplasmic inclusions with neurodegenerative changes in striatonigral or olivopontocerebellar
structures.

Criteria for the diagnosis of probable
MSA
A sporadic, progressive, adult (>30 y)onset disease characterized by:

Criteria for possible MSA
A sporadic, progressive, adult (>30 y)-onset
disease characterized by:

Autonomic failure involving urinary
incontinence (inability to control the release
of urine from the bladder, with erectile
dysfunction in males) or an orthostatic
decrease of blood pressure within 3 min of
standing by at least 30 mm Hg systolic or 15
mm Hg diastolic and

Parkinsonism (bradykinesia with rigidity, tremor,
or postural instability) or

Poorly levodopa-responsive parkinsonism
(bradykinesia with rigidity, tremor, or postural
instability) or

A cerebellar syndrome (gait ataxia with
cerebellar dysarthria, limb ataxia, or
cerebellar oculomotor dysfunction)

A cerebellar syndrome (gait ataxia with cerebellar
dysarthria, limb ataxia, or cerebellar oculomotor
dysfunction) and
At least one feature suggesting autonomic
dysfunction (otherwise unexplained urinary
urgency, frequency or incomplete bladder
emptying, erectile dysfunction in males, or
significant orthostatic blood pressure decline
that does not meet the level required in
probable MSA) and
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Introduction

Case Description
A 64 y/o hispanic male was brought to the hospital by his family with confusion &
hallucinations. His vital signs were within normal limits except for positive orthostatics. Pertinent
exam findings included scanned speech, head titubation, glabellar sign & positive grasp reflex,
increased tone in upper extremities and trunchal rigidity. Cerebellar signs were also abnormal with
ataxic gait. Initial work up included infectious, neoplastic, and metabolic causes, all of which were
negative. Several days into the hospitalization, additional history was obtained from the family. The
patient had a history of long standing progressive deterioration in gait and balance. He also had
increasingly frequent falls. Also mentioned, were changes in mood, behavior, and a history of urinary
incontinence. Complicating these findings was a history of drugs and alcohol use by the patient years
before. The patient has a sister with a similar condition and features, but the sister does not have any
history of drug or alcohol abuse and functions at a higher level despite her older age. Based on
history and physical exam, the diagnosis of probable MSA with predominant cerebellar ataxia was
made. An MRI of the brain showed cerebellar atrophy with pontine flattening. The patient was
treated with atypical antipsychotics while receiving supportive care including physical and
occupational therapy.
Conclusion
This case illustrates the presence of familial MSA with genetic predisposition. MSA is a rare
condition that may not be easily recognized. There is only one known study from Germany
suggesting that genetic predisposition in MSA does occur. In addition, our case stresses the
importance of good history and physical exam to diagnose this condition. Although unusual, Internists
should familiarize themselves with MSA and the various presentation of the disease.

Possible MSA-P

Possible MSA-C

Babinski sign with hyperreflexia

Rapidly progressive
parkinsonism

Parkinsonism (bradykinesia and
rigidity)

MSA is a term that includes together groups of neurodegenerative
disorders.
MSA with predominant Parkinsonism (MSA-P)
Striatonigral Degeneration
MSA with predominant Cerebellar Ataxia(MSA-C)
Olivopontocerebellar Atrophy
MSA with Autoimmune Failure
Shy-Drager Syndrome

Epidemiology

Mean age on onset is 54 year (Range: 31-78 year).
Affects men 2-9 times more than women.
Race: common in Caucasian, African and Asian population.
Prevalence of MSA is 2-5 cases/100,000 population.
Etiology

The cause of MSA is unknown.
Usually sporadic.
Familial MSA with genetic predisposition : autosomal recessive
or dominant inheritance has been reported. There is only one
study from Germany suggesting that genetic predisposition in
MSA does occur.
Pathology and Pathogenesis

Hallmark of MSA: Glial cytoplasmic inclusions and alpha-synuclein
immuno-staining as a sensitive marker of MSA.
The pathologic distribution of glial cytoplasmic inclusion along with
the degree of neuronal loss within specific region of neuraxis
primarily determine the clinical presentation of MSA.
Typical sites of pathologic involvement include the
putamen,caudate nucleus, striatonigral ,locus ceruleus,pontine
nucleus, inferior olivary nucleus, purkinje cell layer of the
cerebellum and interomediolateral cell column.

At least one of the additional features shown in
Table 3

Possible MSA-P or MSA-C

Multiple System Atrophy

Clinical Presentation

Stridor
Poor response to levodopa
Postural instability within 3
y of motor onset
Gait ataxia, cerebellar
dysarthria, limb ataxia, or
cerebellar oculomotor
dysfunction

Atrophy on MRI of putamen, middle
cerebellar peduncle, or pons

The main clinical features of MSA are akinetic-rigid parkinsonism,
autonomic failure, urogenital dysfunction, cerebellar ataxia, and
pyramidal signs in varying combinations.
The onset of disease is marked by the initial clinical manifestation
of any of its characteristic motor or autonomic features.

Hypometabolism onFDG-PET in
putamen
Presynaptic nigrostriatal dopaminergic
denervation on SPECT or PET

Diagnosis

The diagnosis of MSA is based upon the clinical features.
No lab or imaging studies are diagnostic.
MRI brain: Atrophy of cerebellum and brainstem in OPCA and SND.
Hyperintensity in pons, peduncles, and cerebellum on T2-weighted
and proton density–weighted MRIs.
Positron Emission Tomography.
Autonomic Function Testing.
Sphincter Electromyography.

Dysphagia within 5 y of
motor onset
Atrophy on MRI of
putamen, middle cerebellar
peduncle, pons, or
cerebellum

Supporting features

Orofacial dystonia
Disproportionate antecollis
Camptocormia (severe anterior flexion of the spine)
and/or Pisa syndrome (severe lateral flexion of the spine)
Contractures of hands or feet
Inspiratory sighs
Severe dysphonia
Severe dysarthria
Cold hands and feet
Pathologic laughter or crying
Jerky, myoclonic postural/action tremor

Differential Diagnosis

Non supporting features

Classic pill-rolling rest tremor
Clinically significant neuropathy
Hallucinations not induced by drugs
Onset after age 75 y
Family history of ataxia or parkinsonism
Dementia (on DSM-IV)

Rule out malignancy: Paraneoplastic Syndrome.
Other forms of Spinocerebellar Ataxia.
Progressive Supranuclear Palsy.
Idiopathic Parkinsonism Disease:
- In MSA: poor response to dopamine therapy because of loss
of post synaptic dopamine receptors. Peripheral autonomic nervous
system is spared.

MRI Brain showing atrophy of cerebellum with pontine flattening

Treatment

White matter lesions suggesting multiple
sclerosis

No current therapy can reverse or halt progression of the disease.
Supportive care: physical therapy/occupational therapy.
Symptomatic treatment for orthostatic hypotension.
Levodopa, dopaminergic agonists, or anticholinergic agents: These
agents have very minimal response in MSA

Reference: Gilman,S, Wenning, GK, Low, PA,et al. Second Consensus Statement on the Diagnosis of Multiple System Atrophy. Neurology
2008;71:670

Multi-disciplinary approach for treating MSA patient.
Gallyas–Braak staining shows cytoplasmic inclusions in the cortex
(A), and basal ganglia (B).
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